228 related articles for article (PubMed ID: 33213060)
1. Integrity of the Antiviral STING-mediated DNA Sensing in Tumor Cells Is Required to Sustain the Immunotherapeutic Efficacy of
Froechlich G; Caiazza C; Gentile C; D'Alise AM; De Lucia M; Langone F; Leoni G; Cotugno G; Scisciola V; Nicosia A; Scarselli E; Mallardo M; Sasso E; Zambrano N
Cancers (Basel); 2020 Nov; 12(11):. PubMed ID: 33213060
[TBL] [Abstract][Full Text] [Related]
2. Diminished Innate Antiviral Response to Adenovirus Vectors in cGAS/STING-Deficient Mice Minimally Impacts Adaptive Immunity.
Anghelina D; Lam E; Falck-Pedersen E
J Virol; 2016 Jul; 90(13):5915-27. PubMed ID: 27076643
[TBL] [Abstract][Full Text] [Related]
3. Oncolytic virus immunotherapy induces immunogenic cell death and overcomes STING deficiency in melanoma.
Bommareddy PK; Zloza A; Rabkin SD; Kaufman HL
Oncoimmunology; 2019; 8(7):1591875. PubMed ID: 31143509
[TBL] [Abstract][Full Text] [Related]
4. Herpes Simplex Virus 1 Serine Protease VP24 Blocks the DNA-Sensing Signal Pathway by Abrogating Activation of Interferon Regulatory Factor 3.
Zhang D; Su C; Zheng C
J Virol; 2016 Jun; 90(12):5824-5829. PubMed ID: 27076640
[TBL] [Abstract][Full Text] [Related]
5. Ovarian Cancer Cells Commonly Exhibit Defective STING Signaling Which Affects Sensitivity to Viral Oncolysis.
de Queiroz NMGP; Xia T; Konno H; Barber GN
Mol Cancer Res; 2019 Apr; 17(4):974-986. PubMed ID: 30587523
[TBL] [Abstract][Full Text] [Related]
6. Inactivation of the DNA-sensing pathway facilitates oncolytic herpes simplex virus inhibition of pancreatic ductal adenocarcinoma growth.
Zhang N; Guan Y; Li J; Yu J; Yi T
Int Immunopharmacol; 2023 Nov; 124(Pt B):110969. PubMed ID: 37774484
[TBL] [Abstract][Full Text] [Related]
7. The cGas-Sting Signaling Pathway Is Required for the Innate Immune Response Against Ectromelia Virus.
Cheng WY; He XB; Jia HJ; Chen GH; Jin QW; Long ZL; Jing ZZ
Front Immunol; 2018; 9():1297. PubMed ID: 29963044
[TBL] [Abstract][Full Text] [Related]
8. Herpes Simplex Virus 1 UL24 Abrogates the DNA Sensing Signal Pathway by Inhibiting NF-κB Activation.
Xu H; Su C; Pearson A; Mody CH; Zheng C
J Virol; 2017 Apr; 91(7):. PubMed ID: 28100608
[TBL] [Abstract][Full Text] [Related]
9. STING-dependent cytosolic DNA sensing mediates innate immune recognition of immunogenic tumors.
Woo SR; Fuertes MB; Corrales L; Spranger S; Furdyna MJ; Leung MY; Duggan R; Wang Y; Barber GN; Fitzgerald KA; Alegre ML; Gajewski TF
Immunity; 2014 Nov; 41(5):830-42. PubMed ID: 25517615
[TBL] [Abstract][Full Text] [Related]
10. cGAS-STING pathway in oncogenesis and cancer therapeutics.
Hoong BYD; Gan YH; Liu H; Chen ES
Oncotarget; 2020 Jul; 11(30):2930-2955. PubMed ID: 32774773
[TBL] [Abstract][Full Text] [Related]
11. Potent STING activation stimulates immunogenic cell death to enhance antitumor immunity in neuroblastoma.
Wang-Bishop L; Wehbe M; Shae D; James J; Hacker BC; Garland K; Chistov PP; Rafat M; Balko JM; Wilson JT
J Immunother Cancer; 2020 Mar; 8(1):. PubMed ID: 32169869
[TBL] [Abstract][Full Text] [Related]
12. Dual Ligand Insertion in gB and gD of Oncolytic Herpes Simplex Viruses for Retargeting to a Producer Vero Cell Line and to Cancer Cells.
Petrovic B; Leoni V; Gatta V; Zaghini A; Vannini A; Campadelli-Fiume G
J Virol; 2018 Mar; 92(6):. PubMed ID: 29263257
[TBL] [Abstract][Full Text] [Related]
13. STING-Dependent Cytosolic DNA Sensing Promotes Radiation-Induced Type I Interferon-Dependent Antitumor Immunity in Immunogenic Tumors.
Deng L; Liang H; Xu M; Yang X; Burnette B; Arina A; Li XD; Mauceri H; Beckett M; Darga T; Huang X; Gajewski TF; Chen ZJ; Fu YX; Weichselbaum RR
Immunity; 2014 Nov; 41(5):843-52. PubMed ID: 25517616
[TBL] [Abstract][Full Text] [Related]
14. Conservation of the STING-Mediated Cytosolic DNA Sensing Pathway in Zebrafish.
Ge R; Zhou Y; Peng R; Wang R; Li M; Zhang Y; Zheng C; Wang C
J Virol; 2015 Aug; 89(15):7696-706. PubMed ID: 25972544
[TBL] [Abstract][Full Text] [Related]
15. Reovirus combined with a STING agonist enhances anti-tumor immunity in a mouse model of colorectal cancer.
Sugimura N; Kubota E; Mori Y; Aoyama M; Tanaka M; Shimura T; Tanida S; Johnston RN; Kataoka H
Cancer Immunol Immunother; 2023 Nov; 72(11):3593-3608. PubMed ID: 37526659
[TBL] [Abstract][Full Text] [Related]
16. Role of the cGAS-STING pathway in cancer development and oncotherapeutic approaches.
Khoo LT; Chen LY
EMBO Rep; 2018 Dec; 19(12):. PubMed ID: 30446584
[TBL] [Abstract][Full Text] [Related]
17. The Antiviral Apparatus: STING and Oncolytic Virus Restriction.
Lee J; Ghonime MG; Wang R; Cassady KA
Mol Ther Oncolytics; 2019 Jun; 13():7-13. PubMed ID: 30989105
[TBL] [Abstract][Full Text] [Related]
18. A Strategy for Cultivation of Retargeted Oncolytic Herpes Simplex Viruses in Non-cancer Cells.
Leoni V; Gatta V; Casiraghi C; Nicosia A; Petrovic B; Campadelli-Fiume G
J Virol; 2017 May; 91(10):. PubMed ID: 28250120
[TBL] [Abstract][Full Text] [Related]
19. Role of the DNA Sensor STING in Protection from Lethal Infection following Corneal and Intracerebral Challenge with Herpes Simplex Virus 1.
Parker ZM; Murphy AA; Leib DA
J Virol; 2015 Nov; 89(21):11080-91. PubMed ID: 26311879
[TBL] [Abstract][Full Text] [Related]
20. A fully-virulent retargeted oncolytic HSV armed with IL-12 elicits local immunity and vaccine therapy towards distant tumors.
Leoni V; Vannini A; Gatta V; Rambaldi J; Sanapo M; Barboni C; Zaghini A; Nanni P; Lollini PL; Casiraghi C; Campadelli-Fiume G
PLoS Pathog; 2018 Aug; 14(8):e1007209. PubMed ID: 30080893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
